2019
DOI: 10.1002/jcb.29324
|View full text |Cite
|
Sign up to set email alerts
|

Resistance of human primary mesenchymal stem cells to cytotoxic effects of nutlin‐3 in vitro

Abstract: Background The small‐molecule nutlin‐3 was found to be an effective therapeutic compound and p53 activator, and acts as a murine double minute 2 antagonist, although these findings need to be clinically confirmed. The essential components of the bone marrow include mesenchymal stem cells (MSCs), which play a key role in protecting, regenerating, and proliferating hematopoietic stem cells (HSCs). This feature is vital for HSC after exposure to myelotoxic anticancer agents; nevertheless, the effects of nutlin‐3 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 56 publications
(181 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?